LINCOLN NATIONAL CORP
For the period ended Dec 31, 2025. Filed Feb 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 19, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Results of Group Protection
Details underlying the results for Group Protection (in millions) were as follows:
| For the Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Operating Revenues | |||
| Insurance premiums | $5,490 | $5,145 | $5,014 |
| Net investment income | 376 | 348 | 339 |
| Other revenues (1) | 236 | 224 | 210 |
| Total operating revenues | 6,102 | 5,717 | 5,563 |
| Operating Expenses | |||
| Benefits and policyholder liability remeasurement | 3,814 | 3,692 | 3,732 |
| Interest credited | 2 | 6 | 5 |
| Commissions and other expenses | 1,613 | 1,481 | 1,447 |
| Total operating expenses | 5,429 | 5,179 | 5,184 |
| Income (loss) from operations before taxes | 673 | 538 | 379 |
| Federal income tax expense (benefit) | 141 | 113 | 80 |
| Income (loss) from operations | $532 | $425 | $299 |
(1)Consists of revenue from third parties for administrative services performed, which has a corresponding partial offset in commissions and other expenses.
| For the Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Income (Loss) from Operations by Product Line | |||
| Life | $160 | $110 | $70 |
| Disability | 381 | 323 | 237 |
| Dental | (9) | (8) | (8) |
| Income (loss) from operations | $532 | $425 | $299 |
Income from operations for this segment increased due primarily to the following:
Higher insurance premiums due to growth in business in force and persistency.
Higher net investment income, net of interest credited, driven by growth in business in force.
The increase in income from operations was partially offset by the following:
Higher commissions and other expenses due to incentive compensation as a result of production performance and higher other costs pertaining to business operations.
Higher benefits and policyholder liability remeasurement driven by less favorable claims experience than expected in our disability business and growth in business in force, partially offset by the impact of our annual assumption review and lower incidence in our life business.
See “Summary of Critical Accounting Estimates – Annual Assumption Review” for information on the impacts from our annual assumption review.
Management compares trends in actual loss ratios to pricing expectations as group-underwriting risks change over time. We expect normal fluctuations in our total loss ratio, as claims experience is inherently volatile. For every one percent increase in the total loss ratio, we would expect an estimated annual decrease to income from operations of $41 million to $46 million. The effects are symmetrical for a comparable decrease in the loss ratio and, therefore, move in an equal and opposite direction.
For information on the effects of current interest rates on our long-term disability claim reserves, see “Part II– Item 7A. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk – Effect of Interest Rate Sensitivity.” For information on the interest rate environment, see “Introduction – Executive Summary – Industry Trends – Interest Rate Environment” above.
Details underlying insurance premiums (in millions) were as follows:
| For the Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Insurance Premiums by Product Line | |||
| Life | $2,158 | $2,001 | $1,938 |
| Disability | 3,142 | 2,962 | 2,892 |
| Dental | 190 | 182 | 184 |
| Total insurance premiums | $5,490 | $5,145 | $5,014 |
| Sales by Product Line | |||
| Life | $390 | $392 | $333 |
| Disability | 397 | 414 | 311 |
| Dental | 64 | 50 | 49 |
| Total sales | $851 | $856 | $693 |
Premiums are a function of the rates priced into the product and our business in force. Business in force, in turn, is driven by sales and persistency experience.
Sales relate to new policyholders and new coverages sold to existing policyholders. We believe that the trend in sales is an important indicator of development of business in force over time. Sales in the table above are the combined annualized premiums for our products. Generally, we have higher sales during the fourth quarter of the year.
We use our investment income to offset the earnings effect of the associated build of our reserves, which are a function of our insurance premiums and the yields on our investments. Details underlying net investment income (in millions) were as follows:
| For the Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Net Investment Income | |||
| Fixed maturity AFS securities, mortgage loans on real | |||
| estate and other, net of investment expenses | $294 | $269 | $268 |
| Commercial mortgage loan prepayment and bond | |||
| make-whole premiums (1) | 2 | 2 | 1 |
| Surplus investments (2) | 80 | 77 | 70 |
| Total net investment income | $376 | $348 | $339 |
(2)Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities. See “Consolidated Investments – Alternative Investments” below for more information on alternative investments.
Details underlying benefits and policyholder liability remeasurement (in millions) and loss ratios by product line were as follows:
| For the Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Benefits and Policyholder Liability | |||
| Remeasurement by Product Line | |||
| Life | $1,457 | $1,424 | $1,434 |
| Disability | 2,211 | 2,134 | 2,163 |
| Dental | 148 | 140 | 140 |
| Total benefits and policyholder liability | |||
| remeasurement by product line | $3,816 | $3,698 | $3,737 |
| Loss Ratios by Product Line | |||
|---|---|---|---|
| Life | 67.5% | 71.1% | 74.0% |
| Disability | 70.4% | 72.1% | 74.8% |
| Dental | 78.0% | 77.0% | 76.1% |
| Total | 69.5% | 71.9% | 74.5% |
Generally, we experience higher mortality in the first quarter of the year and higher disability claims in the fourth quarter of the year due to the seasonality of claims. For additional information on our loss ratios, see “Additional Information” above.
| For the Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Commissions and Other Expenses | |||
| Commissions | $541 | $462 | $446 |
| General and administrative expenses | 915 | 870 | 846 |
| Taxes, licenses and fees | 140 | 138 | 133 |
| Other | 4 | 3 | 3 |
| Total expenses incurred | 1,600 | 1,473 | 1,428 |
| DAC deferrals | (142) | (135) | (113) |
| Total expenses recognized before amortization | 1,458 | 1,338 | 1,315 |
| DAC and other intangible amortization | 155 | 143 | 132 |
| Total commissions and other expenses | $1,613 | $1,481 | $1,447 |
| DAC Deferrals | |||
|---|---|---|---|
| As a percentage of insurance premiums | 2.6% | 2.6% | 2.3% |
Commissions and other expenses that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable and are amortized on a constant level basis over the expected term of the related contracts using the groupings and actuarial assumptions consistent with those used for calculating the related policyholder liability balances. Certain broker commissions that vary with and are related to paid premiums are expensed as incurred rather than deferred and amortized.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.